Epidemiology Practice Questions

Q: Which of the following cancers is least amenable to screening?

Lung. **Explanation:** The amenability of a cancer to screening depends on the availability of a test that is sensitive, specific, cost-effective, and capable of detecting the disease in a long **pre-clinical phase (lead time)** where intervention can alter the prognosis. **Why Lung Cancer is the Correct Answer:** Lung cancer is considered least amenable to mass screening because it has a very short natural history and high fatality rate. By the time most lung cancers are detectable via conventional screening (like Chest X-ray), they have often already metastasized. While Low-Dose CT (LDCT) is used for high-risk individuals, it is not suitable for mass screening due to high false-positive rates, cost, and the risk of overdiagnosis. Historically, studies have shown that mass screening for lung cancer does not significantly reduce overall mortality in the general population. **Analysis of Incorrect Options:** * **Cervix:** Highly amenable. It has a long pre-invasive stage (CIN) and a highly effective, low-cost screening tool (Pap smear/VIA) that has drastically reduced mortality. * **Breast:** Amenable through Mammography and Clinical Breast Examination (CBE). These tools can detect small, localized tumors before they become palpable, significantly improving survival rates. * **Oral Cavity:** Highly amenable, especially in India. It is easily accessible for visual inspection (Oral Visual Screening) and has identifiable premalignant lesions (e.g., leukoplakia). **High-Yield Pearls for NEET-PG:** * **Wilson and Jungner Criteria:** The gold standard criteria used to decide if a disease should be screened. * **Iceberg Phenomenon:** Screening is designed to detect the "submerged" portion (unmet need/pre-symptomatic cases). * **Lead Time Bias:** The apparent increase in survival time due to early detection, without actually delaying the time of death. * **Best Screening Tool for Cervix (Resource-limited):** VIA (Visual Inspection with Acetic Acid).

Q: In the demographic cycle, when does the contraction of the demographic gap begin?

Early part of Stage III. ### Explanation The **Demographic Gap** is defined as the difference between the Birth Rate (BR) and the Death Rate (DR). The size of this gap determines the rate of natural population increase. **Why Option C is Correct:** In the Demographic Transition Model, **Stage III (Late Expanding)** is characterized by a **sharp decline in the Birth Rate**, while the Death Rate continues to fall but at a much slower pace or begins to level off. Because the Birth Rate starts falling faster than the Death Rate during the **early part of Stage III**, the distance between the two lines on the graph begins to narrow. This narrowing is the "contraction of the demographic gap." **Analysis of Incorrect Options:** * **Stage II (Early Expanding):** This stage is marked by a stationary high Birth Rate and a rapidly declining Death Rate. Consequently, the demographic gap **widens** significantly, leading to a "population explosion." * **Late part of Stage III:** By this point, the contraction is already well underway and the population growth is decelerating further. The *onset* of contraction occurs at the transition from Stage II to Stage III. **High-Yield NEET-PG Pearls:** 1. **Stage I (High Stationary):** High BR, High DR (e.g., India in the 1920s). 2. **Stage II (Early Expanding):** High BR, Declining DR. **India is currently transitioning out of this stage** (though many texts still classify India in late Stage II/early Stage III). 3. **Stage IV (Low Stationary):** Low BR, Low DR (e.g., UK, Denmark). 4. **Stage V (Declining):** BR is lower than DR, leading to a negative growth rate (e.g., Germany, Hungary, Japan). 5. **Key Driver:** The decline in Death Rate (Stage II) usually precedes the decline in Birth Rate (Stage III) due to improvements in sanitation and healthcare.

Q: IFA supplementation is an example of which level of disease prevention?

Specific protection. **Explanation:** The correct answer is **Specific Protection**, which is a sub-component of **Primary Prevention**. **Why Specific Protection is correct:** Primary prevention aims to prevent the onset of disease by intervening before the disease process begins. It is divided into two categories: Health Promotion and Specific Protection. **Specific Protection** involves measures directed toward a particular disease or group of diseases. Since Iron and Folic Acid (IFA) supplementation is a targeted nutritional intervention designed specifically to prevent nutritional deficiency anemia, it falls under this category. Other examples include immunizations and the use of condoms to prevent STIs. **Why the other options are incorrect:** * **Primordial Prevention:** This involves preventing the emergence of risk factors (e.g., discouraging children from starting smoking). Since IFA is given when the risk factor (nutritional deficiency/increased demand) is already present or anticipated, it is not primordial. * **Secondary Prevention:** This focuses on early diagnosis and prompt treatment (e.g., screening tests like Pap smears). IFA supplementation is prophylactic, not a diagnostic tool for existing disease. * **Tertiary Prevention:** This aims to reduce disability and facilitate rehabilitation in late stages of disease. **High-Yield Clinical Pearls for NEET-PG:** * **Anemia Mukt Bharat (AMB):** Uses a "6x6x6" strategy. Note the prophylactic IFA dosage for pregnant women: **100 mg elemental Iron and 500 mcg Folic Acid** daily for 180 days, starting from the second trimester. * **Vitamin A Prophylaxis:** Also an example of Specific Protection. * **Key Distinction:** If a question asks for the "Level of Prevention" and "Primary Prevention" is an option alongside "Specific Protection," choose **Primary Prevention** unless the question specifically asks for the sub-type.

Q: In a demographic study of a population, a country with a low birth rate and a low death rate is in which phase?

4th phase. ### Explanation The question refers to the **Demographic Transition Model**, which describes the historical shift of a population from high birth and death rates to low birth and death rates as a country develops. **Why Option D is Correct:** The **4th Phase (Low Stationary Stage)** is characterized by both **low birth rates and low death rates**. In this stage, the population becomes stable (zero population growth). Modern developed nations like Japan, the UK, and many European countries are currently in this phase. The birth rate has declined to match the already low death rate, leading to an aging population. **Why Other Options are Incorrect:** * **Option A (1st Phase - High Stationary):** Characterized by both **high birth and high death rates**. The population remains stable but at a low level. This was seen globally before the industrial revolution. * **Option B (2nd Phase - Early Expanding):** The death rate begins to decline due to better healthcare and sanitation, but the **birth rate remains high**. This leads to the beginning of a "population explosion." * **Option C (3rd Phase - Late Expanding):** The death rate continues to decline further, and the **birth rate also begins to fall**, but the birth rate still exceeds the death rate, leading to continued population growth. **India** is currently considered to be in late Phase 3. **High-Yield Clinical Pearls for NEET-PG:** * **Phase 5 (Declining Stage):** Some models include a 5th stage where the birth rate falls *below* the death rate, leading to a population decrease (e.g., Germany, Hungary). * **India’s Status:** India is transitioning from Phase 3 to Phase 4. * **Key Driver:** The transition from Phase 2 to Phase 3 is primarily driven by improvements in female literacy and access to contraception. * **The "Gap":** The widening gap between birth and death rates in Phase 2 is what causes the most rapid population growth.

Q: If rapidly progressive cancers are missed by a screening test, which type of bias will occur?

Length bias. ### Explanation **Length Bias (Length-time Bias)** occurs because screening tests are inherently more likely to detect slow-growing, indolent tumors because they have a longer "pre-clinical asymptomatic period." Conversely, **rapidly progressive cancers** have a very short window between being detectable by a test and becoming symptomatic. Consequently, these aggressive cases are often missed by periodic screening and present as "interval cancers" between screening rounds. This creates a false impression that the screening program is more effective than it actually is, as it disproportionately identifies patients with a better prognosis. **Analysis of Incorrect Options:** * **Lead-time Bias:** This is an illusion of increased survival time. It occurs when a disease is detected earlier (at the screening stage) than it would have been without screening, but the actual time of death remains unchanged. The patient simply lives longer with the *knowledge* of the disease. * **Selection Bias:** This occurs when the group of people who volunteer for screening (the "worried well") are healthier or more health-conscious than the general population, skewing the results. * **Surveillance Bias (Detection Bias):** This occurs when one group is monitored more closely than another, leading to an increased probability that a condition will be diagnosed in that group. **High-Yield Clinical Pearls for NEET-PG:** * **Length Bias** relates to the **nature/velocity** of the disease (slow vs. fast). * **Lead-time Bias** relates to the **timing** of the diagnosis. * To eliminate the effect of these biases in studies, **mortality rates** (rather than 5-year survival rates) should be compared in a Randomized Controlled Trial (RCT).

Q: Which of the following statements is NOT true regarding the Tuberculin test?

It is a specific test.. ### Explanation The Tuberculin Skin Test (TST), or Mantoux test, is a classic screening tool for latent TB infection. The correct answer is **Option C** because the Tuberculin test is **not a specific test**. **1. Why Option C is the correct answer (Why it is NOT true):** The TST lacks specificity due to cross-reactivity. A false-positive result can occur in individuals previously vaccinated with **BCG** or those infected with **Non-Tuberculous Mycobacteria (NTM)**. Because the Purified Protein Derivative (PPD) contains antigens shared by various mycobacterial species, it cannot distinguish between *M. tuberculosis* infection and other exposures. **2. Analysis of other options:** * **Option A:** In epidemiological surveys, the TST remains the standard tool for estimating the **Annual Risk of Tuberculous Infection (ARTI)** and the overall prevalence of infection in a community. * **Option B:** In the Indian context and for most general populations, an induration of **≥10 mm** is the standard cut-off for a positive result. (Note: ≥5 mm is used for HIV-positive or immunocompromised patients). * **Option D:** Tuberculin "reactors" (those with a positive test) represent the pool of latent infection. Statistically, the majority of new clinical cases of TB emerge from this pre-existing pool of reactors through endogenous reactivation. **High-Yield Clinical Pearls for NEET-PG:** * **Type of Hypersensitivity:** TST is a **Type IV (Delayed-type)** hypersensitivity reaction. * **Reading the Test:** Read results between **48–72 hours**. Measure only the **induration** (palpable hardening), not the erythema. * **False Negatives:** Can occur in miliary TB, malnutrition, HIV/AIDS (anergy), or recent viral infections like Measles. * **Alternative:** The **IGRA (Interferon-Gamma Release Assay)** is more specific than TST as it does not cross-react with the BCG vaccine.

Q: What is the best-known large-sample study program for coronary heart disease?

Framingham Study. **Explanation:** The **Framingham Heart Study** is the correct answer as it is the most iconic and influential large-sample prospective cohort study in the history of epidemiology. 1. **Why Framingham Study is correct:** Started in 1948 in Framingham, Massachusetts, this study initially recruited over 5,000 adults to identify the common factors or characteristics that contribute to **Coronary Heart Disease (CHD)**. It is responsible for coining the term **"risk factors"** and established the link between CHD and cigarette smoking, high blood pressure, high cholesterol, and physical inactivity. It is now in its third generation of participants. 2. **Why other options are incorrect:** * **North Karelia Study:** This was a community-based **intervention** study (not just observational) in Finland aimed at reducing high rates of CHD through lifestyle changes (dietary fat reduction). * **Stanford Study:** Known as the "Stanford Three-Community Study," it was a quasi-experimental study focused on **health education** and communication strategies to reduce cardiovascular risk. * **Oxford Study:** While there are many Oxford studies (e.g., the Oxford Family Planning Association Study), none are as synonymous with the foundational epidemiology of CHD risk factors as Framingham. **High-Yield Clinical Pearls for NEET-PG:** * **Study Design:** Framingham is the classic example of a **Prospective Cohort Study**. * **Key Finding:** It led to the development of the **Framingham Risk Score**, used to predict a patient's 10-year risk of developing cardiovascular disease. * **Incidence:** Cohort studies like Framingham are the best way to determine the **incidence** of a disease. * **Association:** It established that the risk of CHD increases with the number of risk factors present (synergistic effect).

Q: Among males, which of the following is the most common cancer by incidence?

Prostate. **Explanation:** The correct answer is **Prostate**. According to global epidemiological data (GLOBOCAN), prostate cancer is the most common cancer by incidence among males worldwide. **1. Why Prostate is Correct:** Prostate cancer has the highest incidence rate in men globally, largely due to increased life expectancy and the widespread use of Prostate-Specific Antigen (PSA) screening in developed nations. While its mortality rate is lower compared to lung cancer, the sheer number of new cases diagnosed annually makes it the leading malignancy by incidence. **2. Why the Other Options are Incorrect:** * **Lung Cancer:** While lung cancer is the **leading cause of cancer-related mortality** (death) in men globally, it ranks second to prostate cancer in terms of incidence. * **Colon Cancer:** Colorectal cancer is the third most common cancer in men. Its incidence is rising due to sedentary lifestyles and dietary changes but remains lower than prostate and lung cancers. * **Oropharynx:** While head and neck cancers (including oropharynx) are highly prevalent in specific regions like India due to tobacco and betel nut use, they do not surpass the global incidence of prostate cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Global (Males):** Most common incidence = **Prostate**; Most common mortality = **Lung**. * **Global (Females):** Most common incidence and mortality = **Breast**. * **India (Males):** Most common incidence = **Lip/Oral Cavity** (due to tobacco); Most common mortality = **Lung**. * **India (Females):** Most common incidence = **Breast** (Note: Cervical cancer was previously #1 but has been overtaken by breast cancer in most Indian registries). * **Overall (Global):** Breast cancer has now overtaken lung cancer as the most commonly diagnosed cancer worldwide (both sexes combined).

Question 1

Which of the following cancers is least amenable to screening?

Accepted Answer

Lung

Answer

Breast

Answer

Cervix

Answer

Oral cavity

Question 2

In the demographic cycle, when does the contraction of the demographic gap begin?

Accepted Answer

Early part of Stage III

Answer

Early part of Stage II

Answer

Late part of Stage II

Answer

Late part of Stage III

Question 3

Which of the following diseases does not require mandatory surveillance?

Accepted Answer

Viral encephalitis

Answer

Polio

Answer

Malaria

Answer

Relapsing fever

Question 4

IFA supplementation is an example of which level of disease prevention?

Accepted Answer

Specific protection

Answer

Primordial prevention

Answer

Secondary prevention

Answer

Tertiary prevention

Question 5

In a demographic study of a population, a country with a low birth rate and a low death rate is in which phase?

Accepted Answer

4th phase

Answer

1st phase

Answer

2nd phase

Answer

3rd phase

Question 6

If rapidly progressive cancers are missed by a screening test, which type of bias will occur?

Accepted Answer

Length bias

Answer

Lead-time bias

Answer

Selection bias

Answer

Surveillance bias

Question 7

Which of the following statements is NOT true regarding the Tuberculin test?

Accepted Answer

It is a specific test.

Answer

It is the only tool available for estimating the prevalence of TB in a community.

Answer

An induration of 10 mm indicates a positive test.

Answer

New cases occur more commonly in patients who are tuberculin reactors.

Question 8

Goitre is prevalent at higher altitudes. This is an example of which type of association?

Accepted Answer

Indirect association

Answer

Direct association

Answer

Causal association

Answer

Temporal association

Question 9

What is the best-known large-sample study program for coronary heart disease?

Accepted Answer

Framingham Study

Answer

North Karelia Study

Answer

Stanford Study

Answer

Oxford Study

Question 10

Among males, which of the following is the most common cancer by incidence?

Accepted Answer

Prostate

Answer

Colon

Answer

Lung

Answer

Oropharynx

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?